Originally developed for type 2 diabetes, drugs like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) have shown remarkable effectiveness for weight management with patients losing 15-20% of body weight in clinical trials
Side Effects and Precautions Known Risks (Animal Studies + Anecdotal Reports) Potential for over-stimulation of neurogenesis , which is beneficial short-term but may carry unknown long-term risks Some users report: Mild headaches Irritability or emotional blunting Temporary insomnia if taken late in the day Theoretical Risk: Tumor Growth
Refrigeration recommended after opening for optimal stability
Building a supportive environment, the clients and places that keep you moving forward Change is easier with support
If you're in Missouri and want personalized support for metabolic health, weight management, or medication guidance, Missouri Metabolic Health is here to help